Clinical trials
Phase 1 trials in Colombia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 6 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 4 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 4 |
| Libella Gene Therapeutics | 3 |
| Universidad Nacional de Colombia | 3 |
| Hoffmann-La Roche | 2 |
| Malaria Vaccine and Drug Development Center | 2 |
| Unravel Biosciences, Inc. | 2 |
| Access to Advanced Health Institute (AAHI) | 1 |
| Alios Biopharma Inc. | 1 |
| Amgen | 1 |
| BiO2 Medical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leishmaniasis, Cutaneous | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Leishmaniasis | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Malaria | 2 |
| Malaria, Vivax | 2 |
| Alzheimer Disease | 1 |
| Anemia, Sickle Cell | 1 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.